MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Thermo Fisher Scientific DIO Ratio 2011-2026 | TMO
Annual DIO Ratio Thermo Fisher Scientific
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 86.5 | 81.2 | 94.5 | 81.6 | 78.9 | 72.2 | 72.1 | 73 | 71.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 94.5 | 71.6 | 79.1 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
32.2 | - | -6.19 % | $ 10.5 M |  USA |
 |
Agilent Technologies
A
|
97.1 | $ 116.98 | 2.73 % | $ 35.6 B | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 25.38 | 2.19 % | $ 705 M | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Danaher Corporation
DHR
|
87.6 | $ 196.17 | 2.7 % | $ 140 B | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 16.27 | 2.23 % | $ 492 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 17.97 | 1.7 % | $ 958 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
82.1 | $ 94.63 | 1.43 % | $ 11.9 B | USA |
 |
DexCom
DXCM
|
115 | $ 65.54 | 3.85 % | $ 25.6 B | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 16.28 | 1.18 % | $ 178 M |  China |
 |
Co-Diagnostics
CODX
|
1.69 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 109.05 | 1.76 % | $ 8.99 B |  Irlanda |
 |
Illumina
ILMN
|
137 | $ 128.09 | 1.3 % | $ 20.4 B | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
40.4 | $ 80.09 | 2.57 % | $ 5.41 B | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 176.44 | 4.03 % | $ 8.75 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K |  Israel |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 318.47 | 3.81 % | $ 27.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
42.8 | $ 4.84 | 2.0 % | $ 448 M | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 8.37 | 3.85 % | $ 1.07 B | USA |
 |
Natera
NTRA
|
25.8 | $ 212.81 | 1.69 % | $ 20.9 B | USA |
 |
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
173 | $ 1.49 | 3.12 % | $ 447 M | USA |
 |
PerkinElmer
PKI
|
87.6 | - | -0.91 % | $ 14.7 B | USA |
 |
Precipio
PRPO
|
22.7 | $ 27.77 | -2.56 % | $ 44.6 M | USA |
 |
Quotient Limited
QTNT
|
386 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Personalis
PSNL
|
12.1 | $ 6.48 | 5.02 % | $ 384 M | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 274.08 | 1.83 % | $ 22.8 B | USA |
 |
Biomerica
BMRA
|
147 | $ 2.15 | -0.46 % | $ 4.94 M | USA |
 |
BioNano Genomics
BNGO
|
251 | $ 1.18 | 0.85 % | $ 6.43 M | USA |
 |
Interpace Biosciences
IDXG
|
29.1 | $ 2.0 | 0.25 % | $ 8.85 M | USA |